https://www.selleckchem.com/products/Y-27632.html
Cell-based therapeutic strategies have been proposed as an alternative for brain repair after stroke, but their clinical application has been hampered by potential adverse effects in the long term. The present study was designed to test the effect of the secretome of endothelial progenitor cells (EPCs) from stroke patients (scCM) on in vitro human models of angiogenesis and vascular barrier. Two different scCM batches were analysed by mass spectrometry and a proteome profiler. Human primary CD34 -derived endothelial cells (CD34 -ECs) we
Like
Comment
Share
